Shares of Medtronic PLC MDT slid 1.65% to $83.45 Monday, on what proved to be an all-around poor trading session for the ...

Shares of Medtronic PLC MDT rose 1.54% to $84.85 Friday, on what proved to be an all-around favorable trading session for the ...

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

A little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” Cronin has ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

Medtronic's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Read why I am ...

William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful ...

Medtronic (MDT) closed the most recent trading day at $84.85, moving +1.54% from the previous trading session.

The medical robot and pacemaker company isn’t very well known outside of Minnesota, said Mark Smith, vice president for global talent acquisition. Attracting Generation Z, whose members were born ...

The company also has an excellent dividend profile, having raised its payouts for 47 consecutive years. In just three more years, it will join the prestigious clique of Dividend Kings. That makes ...

Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation in key segments. Read more about MDT stock here.